![]() Gracell Gracell Biotechnologies is a clinical-stage biotech company developing cell gene therapies for cancer. | ![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |
Founding Date | Founding Date 2017 | Founding Date 1781 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Suzhou, CN HQ | ||
Employees | Employees 314 | Employees 47,4554% decrease | Employees 5,669 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) 8.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥850.5b (FY, 2026) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥3.7t (FY, 2026) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income (¥607.5m) (FY, 2022) | Net income ¥192b (FY, 2026) | Net income ¥67b (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 4 (Q3, 2020) | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 185m | Total funding raised $ 57.8m | Total funding raised N/A |

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company